Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - anagrelidum - capsule rigide - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum k 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (nigrum), pro capsula. - trattamento della trombocitemia essenziale - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsule - methylphenidati hydrochloridum 20.00 mg, sacchari sphaerae corresp. saccharum max. 112.77 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum q.s., kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 172 (rubrum), e 171, e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsule - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum max. 169.42 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, kalii hydroxidum, e 171, e 172 (rubrum), e 171, e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsule - methylphenidati hydrochloridum 40 mg, sacchari sphaerae corresp. saccharum mg et saccharum max. 225.89 mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), e 172 (nigrum), e 172 (rubrum), drucktinte: pro capsula, lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsule - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum max. 56.48 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - capsule - methylphenidati hydrochloridum 60 mg, sacchari sphaerae, macrogolum 6000, saccharum max. 338.85 mg et ammonio methacrylatis copolymerum b, maydis amylum, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, aqua, color.: e 171, e 172, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 10 mg; retardkapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum 34.1-49.5 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 20 mg; retardkapseln - methylphenidati hydrochloridum 20 mg, sacchari sphaerae corresp. saccharum 68.2-99.7 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - methylphenidati hydrochloridum - equasym xr 30 mg; retardkapseln - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum 102.3-149.8 mg et maydis amylum, povidonum, hypromellosum, macrogola, ethylcellulosum, dibutylis sebacas, kapselhülle: gelatina, e 132, e 171, e 172 (rubrum), drucktinte: lacca, propylenglycolum, natrii hydroxidum, povidonum, ammoniae solutio 28 per centum, e 171, e 172 (nigrum) pro capsula. - adhs, adhd - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - nilotinibum - capsule - nilotinibum 200 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 156.11 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (rubrum), pro capsula. - trattamento della leucemia mieloide cronica - synthetika